Metronidazole-Based Standard of Care with Favorable Tolerability MIAMI BEACH, Fla., March 19, 2026 /PRNewswire/ -- Crescel LLC, an innovative science and technology company, today announced results ...

Results of a multisite randomized trial of Bright IDEAS-Young Adults: Efficacy of problem-solving skills training on distress and health-related quality of life. This is an ASCO Meeting Abstract from ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

As reported by the Twin Cities Business Journal, the $50 million infusion was announced March 25 and will be used to move the ReCET system further into the trial phase. The Business Journal identified ...

In unilateral intermittent exotropia, distance control improved significantly over 3 months of therapy (mean 2.9 to 1.7; ...

The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...